![Joanna Lis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joanna Lis
Direktor/Vorstandsmitglied bei International Society for Pharmacoeconomics & Outcomes Rsch
Profil
Joanna Lis is currently working as a Director at the International Society for Pharmacoeconomics & Outcomes Research.
She has a graduate and doctorate degree from Uniwersytet Jagiellonski and an MBA from Kozminski University.
Aktive Positionen von Joanna Lis
Unternehmen | Position | Beginn |
---|---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Direktor/Vorstandsmitglied | - |
Ausbildung von Joanna Lis
Uniwersytet Jagiellonski | Doctorate Degree |
Kozminski University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Commercial Services |